Literature DB >> 12459520

Dermatitis herpetiformis: problems, progress and prospects.

Lionel Fry1.   

Abstract

Dermatitis herpetiformis (DH) is an IgA mediated blistering skin disease characterized by the presence of granular deposits of IgA in papillary dermis. The major significant advances in our understanding of DH have been the demonstration that DH patients also have coeliac diseases (CD) and that the rash is also gluten dependent. As a result, it is now possible to cure patients by gluten withdrawal from the diet. The other major significant finding has been the presence of IgA in the uninvolved, now used as the diagnostic criterion for the disease. Despite the fact that it has been known for over fifty years that gluten causes the enteropathy of CD, and for over thirty years the rash of DH, it is still not known how gluten produces these effects. Future immunological studies may look at ways of inducing tolerance to gluten peptides once the toxic ones have been identified. Vaccination against gluten peptides may also be possible in those affected with gluten sensitive disorders.

Entities:  

Mesh:

Substances:

Year:  2002        PMID: 12459520

Source DB:  PubMed          Journal:  Eur J Dermatol        ISSN: 1167-1122            Impact factor:   3.328


  18 in total

1.  Dermatitis Herpetiformis: Rare Cutaneous Manifestation of Colon Adenocarcinoma.

Authors:  Justin Hartke; Julian Trevino; Salma Akram
Journal:  J Gastrointest Cancer       Date:  2012-09

2.  Celiac disease of the joint.

Authors:  Ozden Ozyemisci-Taskiran; Mustafa Cengiz; Fatma Atalay
Journal:  Rheumatol Int       Date:  2010-12-09       Impact factor: 2.631

3.  IgA and IgA-specific receptors in human disease: structural and functional insights into pathogenesis and therapeutic potential.

Authors:  Michelle M Gomes; Andrew B Herr
Journal:  Springer Semin Immunopathol       Date:  2006-10-17

Review 4.  Clinical and diagnostic aspects of gluten related disorders.

Authors:  Francesco Tovoli; Chiara Masi; Elena Guidetti; Giulia Negrini; Paola Paterini; Luigi Bolondi
Journal:  World J Clin Cases       Date:  2015-03-16       Impact factor: 1.337

Review 5.  [Dermatitis herpetiformis. A clinical chameleon].

Authors:  C Pfeiffer
Journal:  Hautarzt       Date:  2006-11       Impact factor: 0.751

6.  A new model for dermatitis herpetiformis that uses HLA-DQ8 transgenic NOD mice.

Authors:  Eric Marietta; Kay Black; Michael Camilleri; Patricia Krause; Roy S Rogers; Chella David; Mark R Pittelkow; Joseph A Murray
Journal:  J Clin Invest       Date:  2004-10       Impact factor: 14.808

7.  Gene expression profiling in dermatitis herpetiformis skin lesions.

Authors:  M Dolcino; E Cozzani; S Riva; A Parodi; E Tinazzi; C Lunardi; A Puccetti
Journal:  Clin Dev Immunol       Date:  2012-09-06

Review 8.  Newly described clinical and immunopathological feature of dermatitis herpetiformis.

Authors:  Veronica Bonciolini; Diletta Bonciani; Alice Verdelli; Antonietta D'Errico; Emiliano Antiga; Paolo Fabbri; Marzia Caproni
Journal:  Clin Dev Immunol       Date:  2012-06-03

9.  Celiac disease and dermatologic manifestations: many skin clue to unfold gluten-sensitive enteropathy.

Authors:  Marzia Caproni; Veronica Bonciolini; Antonietta D'Errico; Emiliano Antiga; Paolo Fabbri
Journal:  Gastroenterol Res Pract       Date:  2012-05-30       Impact factor: 2.260

Review 10.  Animal models to study gluten sensitivity.

Authors:  Eric V Marietta; Joseph A Murray
Journal:  Semin Immunopathol       Date:  2012-05-11       Impact factor: 11.759

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.